| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023336 |
| Receipt No. | R000026821 |
| Official scientific title of the study | The relationship among plasma ghrelin level and H. pylori infection and eradication therapy in patients with chronic kidney disease |
| Date of disclosure of the study information | 2016/07/26 |
| Last modified on | 2017/07/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The relationship among plasma ghrelin level and H. pylori infection and eradication therapy in patients with chronic kidney disease | |
| Title of the study (Brief title) | Ghrelin and H. pylori in chronic kidney disease patients | |
| Region |
|
|
| Condition | |||||
| Condition | Hemodialysis patients and non-dialysis patients with chronic kidney disease | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To investigate the associations between plasma ghrelin level and clinical parameters (e.g., nutrition and H. pylori infection, severity of gastric mucosal atrophy) in hemodialysis patients and non-dialysis patients with chronic kidney disease and to clarify improvenemnt of above parameters by H. pylori eradication therapy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Association with plasme ghrelin levels and gastric mucosal atrophy in hemodialysis patients
|
| Key secondary outcomes | 1)Association with plasme ghrelin levels and H. pylori infection in hemodialysis patients
2)H. pyloti infection rate in CKD patients 3)Association with plasme ghrelin levels and mutrition markers in CKD patients 4)Prevalence of the upper gastrointestinal disease in CKD patients 5)Eradication rate of H. pylori in CKD patients 6)Change of plasma ghlerin levels after eradicaion therapy 7)Change of nutrition markers after eradicaion therapy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | H. pylori eradication therapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)With chronic renal dysfunction including hemodialysis
(2)Receiving gastroduodenal endoscopy |
|||
| Key exclusion criteria | (1)Having a H. pylori eradication history
(2)With history of gastrectomy (3)With significant clinical illness (e.g., cancer) (4)Lack of informed consent |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hitomi Ichikawa |
| Organization | Hamamatsu University School of Medicine |
| Division name | First Department of Mediine |
| Address | 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan |
| TEL | 053-435-2261 |
| hito0215@hama-med.ac.jp | |
| Public contact | |
| Name of contact person | Hitomi Ichikawa |
| Organization | Hamamatsu University School of Medicine |
| Division name | First Department of Mediine |
| Address | 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan |
| TEL | 053-435-2261 |
| Homepage URL | |
| hito0215@hama-med.ac.jp | |
| Sponsor | |
| Institute | Hamamatsu University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese Assosiation of Dialysis Physicians |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026821 |